Transdiagnostic Sleep and Anxiety Treatment
A Pilot Study and Randomized Controlled Trial of Transdiagnostic Sleep and Anxiety Treatment
1 other identifier
interventional
61
1 country
1
Brief Summary
Background: Anxiety and insomnia disorders are two of the most common and costly mental health conditions. These disorders are frequently comorbid, but current treatment approaches do not target both. To streamline treatment for these commonly comorbid conditions, a novel, computerized intervention was developed targeting a transdiagnostic factor, safety aids, which are cognitive or behavioral strategies individuals use to cope with distress associated with anxiety or insomnia, that paradoxically exacerbate symptoms. A randomized controlled trial was conducted to determine the acceptability and efficacy of this newly developed intervention. Method: Young adults (N = 61) with elevated anxiety and insomnia symptoms were randomized to receive the anxiety-insomnia intervention or a computerized control condition focused on general physical health behaviors. After the intervention, participants were followed up at one week and one month and completed self-report measures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 12, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 12, 2018
CompletedFirst Submitted
Initial submission to the registry
September 6, 2018
CompletedFirst Posted
Study publicly available on registry
September 10, 2018
CompletedFebruary 1, 2021
January 1, 2021
9 months
September 6, 2018
January 27, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Safety Aid Scale
safety aids. Total score (79-445). Higher score indicates worsened symptoms.
Month 1
Secondary Outcomes (4)
Sleep Related Behavior Questionnaire
Month 1
Penn State Worry Questionnaire
Month 1
Dimensional Obsessive Compulsive Scale
Month 1
Insomnia Severity Index
Month 1
Study Arms (2)
FSET Anxiety and Sleep Treatment
EXPERIMENTALThe FSET Anxiety and Sleep Treatment (FAST) is a brief, 45-minute computerized intervention that can be accessed by any device connected to the Internet. The majority of the information is delivered via text. The program contains some interactive features such as quizzes, which direct participants to content, personalized to the individual user (for example screenshots, see Figure 2). FAST contains four modules: motivation, psychoeducation, behavioral tools, and behavior change.
Control
ACTIVE COMPARATORThe control condition is the Physical Health Education Treatment (PHET) used in several of our laboratory's prior studies (Schmidt, Capron, Raines, \& Allan, 2014). PHET is also a 45-minute computerized intervention, including audio and visual features as well as comprehension quizzes.
Interventions
Computerized anxiety and insomnia intervention.
Eligibility Criteria
You may qualify if:
- SD above the mean in anxiety and insomnia symptoms
- Interest in improving anxiety and sleep
You may not qualify if:
- Participating in another clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Anxiety and Behavioral Health Clinic
Tallahassee, Florida, 32306, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 6, 2018
First Posted
September 10, 2018
Study Start
August 1, 2017
Primary Completion
May 12, 2018
Study Completion
May 12, 2018
Last Updated
February 1, 2021
Record last verified: 2021-01